Covid-19 Impact of COVID-19 on Therapeutic Approaches to Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Understand how neurology departments across the US and Canada are rapidly adapting their clinical care delivery systems to minimize risk of SARS-CoV-2 transmission.
Covid-19 COVID-19: Impact on Healthcare Practices and Treatment Decisions The evolving COVID-19 pandemic is causing enormous impact on individuals and the healthcare system. Increasingly, it is also clear that COVID-19 has broad-ranging effects on our workplaces, our economy, and our social interactions.
Conferences AAN 2020 Abstracts Released - What We're Watching in Multiple Sclerosis As of March 13, the AAN annual meeting has been cancelled due to the ongoing global COVID-19 (Coronavirus) pandemic. We'll be keeping a close eye on any plans to hold events digitally and
Research ZoomRx, MGH, and the Sumaira Foundation Collaborate on Newly Published NMO Research When approached by the Global Neurology Research Group at Mass General Hospital (along with the Sumaira Foundation) with the opportunity to collaborate on a global study of neuromyelitis optica (NMO), we were eager
Conferences Breakthrough Treatments and Pharma's Pricing Dilemma - Perspective from AAN 2019 The recent 2019 AAN conference (May 4-10, Philadelphia) brought promising new data in rare diseases, generating a great deal of excitement and anticipation for new therapies.
